Curare modification of suxamethonium blockade

Area of Science:

• Anesthesiology
• Pharmacology
• Neuroscience

Background:

• Neuromuscular blocking agents are crucial in anesthesia.
• Understanding drug interactions at the neuromuscular junction is vital for patient safety.
• Suxamethonium is a common depolarizing neuromuscular blocker, while tubocurare is a non-depolarizing agent.

Purpose of the Study:

• To investigate the effect of pre-administered tubocurare on the neuromuscular blocking characteristics of suxamethonium.
• To analyze the onset, intensity, and duration of a modified neuromuscular block.
• To explore the mechanism of train-of-four fade in combined blockade.

Main Methods:

• Electromyographic responses were measured in patients anesthetized with enflurane.
• A train-of-four stimulation (0.2 Hz) was applied every 20 seconds.
• Tubocurare was administered 10 seconds prior to suxamethonium at specific dosages.

Main Results:

• The modified block (tubocurare + suxamethonium) exhibited a slower onset, reduced intensity, and shorter duration compared to suxamethonium alone.
• However, the modified block's characteristics were closer to suxamethonium than to tubocurare.
• Train-of-four fade during the onset of the modified block was similar to tubocurare controls and significantly different from the suxamethonium group.

Conclusions:

• Effective concentrations of tubocurare reach the neuromuscular junction within 30 seconds of IV injection, influencing suxamethonium's onset.
• The presence of train-of-four fade during a primarily agonist block challenges explanations based solely on reduced acetylcholine release or postsynaptic action of suxamethonium.